Mutual Advisors LLC Sells 267 Shares of CME Group Inc. $CME

Mutual Advisors LLC trimmed its stake in CME Group Inc. (NASDAQ:CME) by 9.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,479 shares of the financial services provider’s stock after selling 267 shares during the period. Mutual Advisors LLC’s holdings in CME Group were worth $693,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Webster Bank N. A. grew its holdings in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the last quarter. Highline Wealth Partners LLC grew its holdings in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares during the last quarter. Wayfinding Financial LLC bought a new stake in shares of CME Group during the first quarter worth $25,000. Cornerstone Planning Group LLC grew its holdings in shares of CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Finally, Trifecta Capital Advisors LLC grew its holdings in shares of CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard purchased 262 shares of the stock in a transaction on Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the acquisition, the director directly owned 258,459 shares of the company’s stock, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company’s stock, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 13,043 shares of company stock worth $3,527,956. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on CME. Barclays decreased their target price on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 8th. Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Morgan Stanley upped their price target on CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research note on Wednesday, October 1st. Oppenheimer upped their price target on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Finally, TD Cowen upped their price target on CME Group from $281.00 to $288.00 and gave the company a “hold” rating in a research note on Wednesday, October 8th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $283.71.

CME Group Trading Up 2.1%

NASDAQ:CME opened at $267.93 on Friday. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The business’s 50-day moving average price is $267.30 and its two-hundred day moving average price is $271.38. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $96.56 billion, a price-to-earnings ratio of 25.94, a PEG ratio of 6.16 and a beta of 0.41.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the firm posted $2.56 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis. On average, equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.